IMMUNE-MEDIATED MOVEMENT DISORDERS: CLINICAL MANIFESTATIONS, TREATMENT, AND EVOLUTION. A MULTICENTER STUDY
Objective: To evaluate the clinical characteristics, etiologies, treatment, and evolution of patients with immune-mediated movement disorders(IMMD). Background: The highly variable and complex phenomenology of IMMD and…Parkinson’s disease and Post-COVID-19 syndrome
Objective: To report the prevalence of Post-Corona Virus Disease 2019 (COVID-19) syndrome in a case series of Parkinson’s disease (PD) patients. Background: Implications of COVID-19…Tele and video consultations of patients with parkinsonism in the Brazilian public health system – a real life feasibility study
Objective: To evaluate the feasibility and identify obstacles in conducting teleconsultations for patients with parkinsonism in the Brazilian public health system Background: Patients with parkinsonism…Efficacy of opicapone according to levodopa’s duration of use in Parkinson’s disease patients with motor fluctuations
Objective: To evaluate the efficacy of opicapone (OPC) in Parkinson’s disease (PD) patients with motor fluctuation (MF) according to levodopa’s duration of use. Background: OPC…Non-motor symptoms in Parkinson’s disease
Objective: The objective of our study is to assess the prevalence of non motor signs in patients with parkinson’s disease and to propose an adapted…Dual-task interference on weight-shifting in Parkinson’s Disease with freezing of gait and without freezing of gait
Objective: To investigate the control of dual-task weight-shifting in Parkinson's disease (PD) with freezing of gait (FOG) and without FOG). Background: With more impairment in…Cuneiform Nucleus Deep Brain Stimulation for Freezing of Gait in Parkinson’s disease. Initial clinical report.
Objective: Here we report a first in human targeting of Cuneiform Nucleus (CnF) using MR tractography, observation of intraoperative stimulation patterns and stimulation precision benefits of…A Phase 2 Randomized Controlled Trial Repurposing Ambroxol as a Disease Modifying Treatment for Parkinson’s Disease Dementia.
Objective: Currently there are no disease-treatments for Synucleinopathies including Parkinson’s disease dementia (PDD). Our objective is to use Ambroxol to target GBA/Glucocerebrosidase to treat PDD.…Secondary endpoints of a randomized, placebo-Controlled Pilot Study to evaluate the safety of lyophilized PRIM-DJ2727 in Parkinson’s disease
Objective: To evaluate the impact of fecal microbiome transplant (FMT) on disease progression as a secondary outcome of a safety study using PRIM-DJ2727 in Parkinson's…The effect of medical xenon on patients with advanced stages of the Parkinson’s disease with motor fluctuations
Objective: The aim of the study to increase the effectiveness of pharmacotherapy in patients with advanced stages of Parkinson's disease (PD) with motor fluctuations, using…
- « Previous Page
- 1
- …
- 67
- 68
- 69
- 70
- 71
- …
- 132
- Next Page »